{
    "Authorities": [
        {
            "Organization": "FDA",
            "Standards": [
                {
                    "Name": "SDTMIG",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "3.2"
                },
                {
                    "Name": "SDTMIG",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "3.3"
                },
                {
                    "Name": "SDTMIG",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "3.4"
                },
                {
                    "Name": "SENDIG",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "3.0"
                },
                {
                    "Name": "SENDIG",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "3.1"
                },
                {
                    "Name": "SENDIG",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "3.1.1"
                },
                {
                    "Name": "SENDIG-GENETOX",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "1.0"
                },
                {
                    "Name": "SENDIG-DART",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "1.1"
                },
                {
                    "Name": "SENDIG-DART",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "1.2"
                },
                {
                    "Name": "SENDIG-AR",
                    "References": [
                        {
                            "Citations": [
                                {
                                    "Cited_Guidance": "The value for study day should not be negative for exposure treatments.",
                                    "Document": "FDA",
                                    "Section": "FDAB036"
                                }
                            ],
                            "Origin": "FDA Business Rules",
                            "Rule_Identifier": {
                                "Id": "FB3601",
                                "Version": "1"
                            },
                            "Version": "1.5"
                        }
                    ],
                    "Version": "1.0"
                }
            ]
        }
    ],
    "Check": {
        "any": [
            {
                "name": "--STDY",
                "operator": "less_than",
                "value": 0
            },
            {
                "name": "--ENDY",
                "operator": "less_than",
                "value": 0
            }
        ]
    },
    "Core": {
        "Id": "CORE-000516",
        "Status": "Published",
        "Version": "1"
    },
    "Description": "Study Day variables (--DY) value should not be negative in Exposure (EC/EX) datasets.",
    "Executability": "Fully Executable",
    "Outcome": {
        "Message": "Negative value of Study Day variable",
        "Output_Variables": [
            "--STDY",
            "--ENDY"
        ]
    },
    "Rule_Type": "Record Data",
    "Scope": {
        "Classes": {
            "Include": [
                "INTERVENTIONS"
            ]
        },
        "Domains": {
            "Include": [
                "EC",
                "EX"
            ]
        }
    },
    "Sensitivity": "Record"
}